X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 17/08/2024 14:16

Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types of leukaemia, the approach has yet to realise its potential against paediatric solid tumours. Scientists at St. Jude Children’s Research Hospital have identified a way to improve CAR T–cell homing – a T cell’s ability [...]

Articles similaires

Sorry! Image not available at this time

'Weaponised' CAR T-cell therapy shows promise against solid tumours

wn.com - 23/Oct 10:33

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid cancers - but a study in...

Mitochondria and lysosomes work together to control regulatory T cell activation

news.medical.net - 02:27

Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system.

CRATERs identified as key sites for T cell-mediated tumor destruction

news.medical.net - 18/Oct 03:42

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma cells that serve as...

Research lab publishes breakthrough on mRNA cancer vaccines

oncologynews.com.au - 23/Oct 23:39

Cancer Centre at Illinois (CCIL), USA, member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. Wang’s study...

Could Covid-19 vaccines secretly boost cancer survival? Scientists say mRNA shows unexpected potential to aid cancer treatment

times of india - 23/Oct 07:32

New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune system to target and attack...

First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial

news.medical.net - 01:49

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing...

Sorry! Image not available at this time

Biology teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

wn.com - 00:33

Emily Henders, 37, received her CAR T-cell therapy last week and hopes it will slow down or halt progression of her MS. ......

Sorry! Image not available at this time

mRNA covid vaccines spark immune response that may aid cancer survival

wn.com - 19/Oct 16:36

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given soon after people start...

Sorry! Image not available at this time

mRNA covid vaccines spark immune response that may aid cancer survival

wn.com - 19/Oct 16:36

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given soon after people start...

Sorry! Image not available at this time

Immunocore Holdings PLC: Oncology Account Manager

pharmiweb.com - 17/Oct 14:42

USD170000 - USD210000 per year + Car, Bonus, Equity, Benefits: Immunocore Holdings PLC: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T...